News
A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.
A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...
Doudna and Charpentier won the Nobel Prize in Chemistry for their discovery of the CRISPR-Cas9 technique, a method of ...
Hosted on MSN19d
Should We Use CRISPR to Create Super-Resistant Farm Animals?Should we embrace this high-tech solution or leave nature untouched? #geneediting #CRISPR #GMOfarming #foodsecurity #bioethics #animalwelfare #geneticengineering #sciencevsnature #futureoffarming ...
Are you dreading the thought of going to work tomorrow? Whether it’s a hot-tempered boss, an unreasonable workload, or malicious coworkers, a toxic work environment can take a significant toll ...
CRISPR gene-editing technology offers curative ... guide Cas proteins to exactly where to cut the DNA. The technique works in any cell and opens the possibility for gene editing in humans, plants ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
Programmable cellular models of embryos, known as embryoids, allow scientists to mimic the first few day of embryonic development. The project team, left to right: Ali Shariati, Sayaka Kozuki, and ...
We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other shorted stocks in 2025.
CRISPR Therapeutics AG (CRSP)’s share was trading ... That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet… And is still used by hundreds of banks, hedge ...
CRISPR Therapeutics AG (CRSP)'s share was trading at $40.97 as of March 18 th. CRSP’s trailing and forward P/E were 22.55 and 23.36 respectively according to Yahoo Finance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results